Michael F. MacLean
Net Worth

Last updated:

What is Michael F. MacLean net worth?

The estimated net worth of Mr. Michael F. MacLean is at least $10,472,005 as of 18 Dec 2024. He owns shares worth $3,659,401 as insider, has earned $6,311,264 from insider trading and has received compensation worth at least $501,340 in Avidity Biosciences, Inc..

What is the salary of Michael F. MacLean?

Mr. Michael F. MacLean salary is $501,340 per year as Chief Financial Officer in Avidity Biosciences, Inc..

How old is Michael F. MacLean?

Mr. Michael F. MacLean is 59 years old, born in 1966.

What stocks does Michael F. MacLean currently own?

As insider, Mr. Michael F. MacLean owns shares in one company:

Company Title Shares Price per share Total value
Avidity Biosciences, Inc. (RNA) Chief Financial Officer 82,942 $44.12 $3,659,401

What does Avidity Biosciences, Inc. do?

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

RNA logo
RNA
Avidity Biosciences, Inc.
$44.12

Michael F. MacLean insider trading

Avidity Biosciences, Inc.

Mr. Michael F. MacLean has made 7 insider trades in 2024, according to the Form 4 filled with the SEC. Most recently he sold 11,151 units of RNA stock worth $364,192 on 18 Dec 2024.

The largest trade he's ever made was exercising 75,000 units of RNA stock on 14 May 2024. As of 18 Dec 2024 he still owns at least 82,942 units of RNA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 11,151 $32.66 $364,192
Option
Stock Option (Right to Buy) 13,875 $6.57 $91,159
Option
Stock Option (Right to Buy) 65,182 $8.82 $574,905
Option
Common Stock 13,875 $6.57 $91,159
Sale
Common Stock 41,137 $45.78 $1,883,087
Option
Common Stock 65,182 $8.82 $574,905
Sale
Common Stock 11,510 $44 $506,440
Sale
Common Stock 11,228 $39.13 $439,340
Option
Stock Option (Right to Buy) 75,000 $8.82 $661,500
Option
Common Stock 75,000 $8.82 $661,500
Sale
Common Stock 75,000 $28.28 $2,121,075
Option
Common Stock 40,000 $8.82 $352,800
Sale
Common Stock 40,000 $24.52 $980,760
Option
Stock Option (Right to Buy) 40,000 $8.82 $352,800
Sale
Common Stock 1,616 $10.13 $16,370

Avidity Biosciences key executives

Avidity Biosciences, Inc. executives and other stock owners filed with the SEC: